Mycio Wealth Partners, LLC Bristol Myers Squibb CO Transaction History

Mycio Wealth Partners, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $802,998 - $1.17 Million	-17,306 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $451,354 - $588,750	9,172 Added 112.76%	17,306 $1.11 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $3,164 - $3,752	74 Added 0.92%	8,134 $412,000
Q2 2019 Aug 05, 2019	BUY	$44.62 - $49.34 $55,998 - $61,921	1,255 Added 18.44%	8,060 $366,000
Q1 2019 Apr 18, 2019	BUY	$45.12 - $53.8 $1,082 - $1,291	24 Added 0.35%	6,805 $325,000
Q4 2018 Jan 22, 2019	SELL	$48.76 - $63.23 $30,475 - $39,518	-625 Reduced 8.44%	6,781 $352,000
Q3 2018 Oct 25, 2018	SELL	$55.19 - $62.25 $21,744 - $24,526	-394 Reduced 5.05%	7,406 $460,000
Q2 2018 Jul 19, 2018	BUY	$50.53 - $62.98 $97,421 - $121,425	1,928 Added 32.83%	7,800 $432,000
Q1 2018 Apr 27, 2018	SELL	$59.92 - $68.98 $51,591 - $59,391	-861 Reduced 12.79%	5,872 $371,000
Q4 2017 Jan 31, 2018	BUY	$59.94 - $65.35 $31,408 - $34,243	524 Added 8.44%	6,733 $413,000
Q3 2017 Oct 19, 2017	BUY	$55.23 - $63.74 $8,174 - $9,433	148 Added 2.44%	6,209 $396,000
Q2 2017 Aug 10, 2017	SELL	N/A	-1,780 Reduced 22.7%	6,061 $338,000
Q2 2017 Aug 08, 2017	BUY	N/A	7,841	7,841 $426,000

2,404

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Mycio Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Mycio Wealth Partners, LLC with notifications on news.